Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2000 | 09-1999 | 09-1998 | 09-1993 | 09-1992 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -138 | 590 | -50 | -2,348 | -552 |
| Depreciation Amortization | 8 | 8 | 10 | 193 | 91 |
| Accounts receivable | 9 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1 | N/A | N/A | N/A | N/A |
| Other Working Capital | 137 | 60 | -10 | -141 | 45 |
| Other Operating Activity | -95 | -688 | 10 | 51 | 230 |
| Operating Cash Flow | $-80 | $-30 | $-40 | $-2,244 | $-187 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 0 | 0 | -168 | -6 |
| Other Investing Activity | 0 | 0 | 0 | -194 | -222 |
| Investing Cash Flow | $-1 | $0 | $0 | $-362 | $-229 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 85 | 30 | 40 | 5,235 | 430 |
| Financing Cash Flow | $83 | $30 | $40 | $5,235 | $430 |
| Beginning Cash Position | 0 | 1 | 1 | 24 | 9 |
| End Cash Position | 2 | 0 | 1 | 2,653 | 24 |
| Net Cash Flow | $2 | $-1 | $0 | $2,629 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -80 | -30 | -40 | -2,244 | -187 |
| Capital Expenditure | -1 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -81 | -30 | -40 | -2,244 | -187 |